Sitting for over 10 hours or more a day is significantly linked to future heart failure and cardiovascular death risk, a new ...

Valuable data can successfully be collected with the noninvasive wearable, which is worn on the sternum, report investigators ...

Both the nasal and IV forms of bumetanide had a variability in absorption of 27%, suggesting a more stable route of dosing ...

We know that exercise is good for our hearts and overall health. But is that true for people living with heart failure? And ...

The second arm of the trial was the placebo arm (n = 367). The final primary endpoints of SUMMIT were a combination of ...

A new study by researchers at Intermountain Health in Salt Lake City finds that 40 percent of newly diagnosed heart failure patients also have atrial fibrillation – a combination of cardiac disorders ...

New research highlights how air pollution exacerbates heart failure, revealing increased inflammation and the need for ...

The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure.

Existing research has tied sedentary behavior to a slew of health problems in both children and adults, from obesity and poor ...

Lilly has reported comprehensive outcomes from the Phase III trial of tirzepatide for individuals with heart failure with ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...